US2010202989A1PendingUtilityA1

Methods for treatment of dermatological conditions

52
Assignee: WANG BINGPriority: Aug 4, 2003Filed: Apr 19, 2010Published: Aug 12, 2010
Est. expiryAug 4, 2023(expired)· nominal 20-yr term from priority
A61Q 19/00A61K 31/195A61K 8/44A61P 17/00A61K 31/44A61K 31/40A61K 45/06A61K 8/498A61Q 19/08A61K 8/49A61K 31/135A61K 31/66
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of reducing the appearance of skin conditions associated with loss of skin tightness, skin firmness, or dark circles under the eyes with topical compositions comprising compounds of any of the Formulae I or Ia as described herein, is disclosed.

Claims

exact text as granted — not AI-modified
1 . A method for reducing the appearance of skin wrinkles, sagging in the eye area or jowls, frown lines, expression lines, striae, stretch marks, loss of skin elasticity, loss of skin tightness, loss of skin firmness, loss of skin recoil from deformation, loss of collagen and elastic fibers, comprising topically applying to affected skin areas a composition comprising at least one compound selected from bis[[(2-hydroxy-ethyl)-imino]diaceto]-cuprate (II), bis[[(2-hydroxy-ethyl)-imino]-diaceto]-zincate (II), bis[[(2-hydroxy-ethyl)-imino]-diaceto]-manganate (II), and isomers, racemic or non-racemic mixtures of isomers, or acceptable salts thereof. 
   
   
       2 . The method of  claim 1  comprising administering a composition comprising at least one compound selected from bis[[(2-hydroxy-ethyl)-imino]diaceto]-cuprate (II), bis[[(2-hydroxy-ethyl)-imino]-diaceto]-zincate (II), bis[[(2-hydroxy-ethyl)-imino]-diaceto]-manganate (II), and isomers, racemic or non-racemic mixtures of isomers, or acceptable salts thereof, with at least one cosmetically acceptable excipient. 
   
   
       3 . The method of  claim 1  wherein said treatment is for improving the appearance of loss of skin elasticity, skin tightness or skin firmness. 
   
   
       4 . The method of  claim 1  wherein said composition further comprises at least one additional benefit agent selected from sunscreens, retinoids, antioxidants, hydroxyacids, fatty acids, acceptable non-toxic organic salts of zinc, copper, or magnesium optionally derived from naturally occurring amino acids or from hydroxyalkyl acids, botanical extracts, salicylic acid, benzoyl peroxide, antibiotics, antiandrogens, anti-inflammatory agents, ascorbic acid, vitamins B, tocopherols or tocotrienols, corticosteroids, or mixtures thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.